2 recruiting, 1 not yet recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow MC-1-50: new trials by email Literature Review of MC-1-50 trials Research Report on MC-1-50
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE MC-1-50 - Systemic Lupus Erythematosus (SLE), Refractory | Phase 1 | Recruiting | Chongqing Precision Biotech Co., Ltd | 12 | 2025-06-12 | 2025-12-22 |
| Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL MC-1-50 - Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia | Phase 1 | Not yet recruiting | Chongqing Precision Biotech Co., Ltd | 24 | 2024-11-01 | 2024-10-15 |
| Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma MC-1-50 - B Cell Lymphoma, Non Hodgkin Lymphoma | Phase 1 | Recruiting | Chongqing Precision Biotech Co., Ltd | 24 | 2023-12-31 | 2023-12-28 |
Lupus Erythematosus, Systemic (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Chongqing Precision Biotech Co., Ltd (3)
China (3)
Yuqin Song, M.D (1)